Pharmacology and structure of isolated conformations of the adenosine A2A receptor define ligand efficacy

Kirstie A. Bennett, Benjamin Tehan, Guillaume Lebon, Christopher G. Tate, Malcolm Weir, Fiona H. Marshall, Christopher J. Langmead

Research output: Contribution to journalArticleResearchpeer-review

40 Citations (Scopus)

Abstract

Using isolated receptor conformations crystal structures of the adenosine A2A receptor have been solved in active and inactive states. Studying the change in affinity of ligands at these conformations allowed qualitative prediction of compound efficacy in vitro in a system-independent manner. Agonist 59- N-ethylcarboxamidoadenosine displayed a clear preference to bind to the active state receptor; inverse agonists (xanthine amine congener, ZM241385, SCH58261, and preladenant) bound preferentially to the inactive state, whereas neutral antagonists (theophylline, caffeine, and istradefylline) demonstrated equal affinity for active and inactive states. Ligand docking into the known crystal structures of the A2A receptor rationalized the pharmacology observed; inverse agonists, unlike neutral antagonists, cannot be accommodated within the agonist-binding site of the receptor. The availability of isolated receptor conformations opens the door to the concept of 'reverse pharmacology' whereby the functional pharmacology of ligands can be characterized in a system-independent manner by their affinity for a pair (or set) of G protein-coupled receptor conformations.

Original languageEnglish
Pages (from-to)949-958
Number of pages10
JournalMolecular Pharmacology
Volume83
Issue number5
DOIs
Publication statusPublished - May 2013

Cite this